CHARITY SLAYTON: Open Payments
NPI 1902229933 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,633 in 155 payments from 23 companies in 2025. Trend: 2023 $3,121 · 2024 $4,998 · 2025 $3,633
Food & beverage: $3,424Education: $209
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $508 |
| ABBVIE INC. | 27 | $471 |
| UCB, Inc. | 17 | $423 |
| Novartis Pharmaceuticals Corporation | 13 | $410 |
| Lilly USA, LLC | 12 | $304 |
| LEO Pharma Inc. | 6 | $241 |
| PFIZER INC. | 7 | $200 |
| Incyte Corporation | 9 | $171 |
| E.R. Squibb & Sons, L.L.C. | 14 | $148 |
| Janssen Scientific Affairs, LLC | 1 | $132 |
Products named: TREMFYA, Bimzelx, SKYRIZI, COSENTYX, OPZELURA, Rhapsido, TALTZ, Sotyktu.
Industry payments across MO — which companies pay providers there.
